Syngene International Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

SYNGENE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+2.2%1-day move

₹409.70

prior close

₹409.50

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.5+0.2-0.3+0.4+2.2-0.4+1.3-3.0-2.3+0.2-1.2+6.4+14.2+9.4

Up moveDown movePending

AI summary

Syngene International has informed the stock exchanges about a scheduled meeting with OrbiMed Advisors LLC, a US-based healthcare-focused investment firm. The meeting will be held virtually on March 19, 2026 at 11:00 AM IST as a one-to-one interaction. The company has clarified that no Unpublished Price Sensitive Information (UPSI) will be disclosed during the meeting. This is a routine regulatory disclosure filed under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements. The announcement is also being made available on the company's website.

Likely market impact

This is a routine compliance filing with no material business or financial disclosure. It signals continued institutional investor engagement but is unlikely to have a direct impact on the stock price.